The Overview: May 2021
Before we head into the long holiday weekend, we wanted to share all the latest news and happenings. See below for updates in ovarian cancer research and advocacy, and discover … Continued
News
OCRA-Funded Research Uncovers New Checkpoint Mechanism, Potential New Therapeutic Target
New research from The Wistar Institute and Peter MacCallum Cancer Center has uncovered a previously unknown checkpoint mechanism for gene expression, that may open up new avenues for transcription-based targeted … Continued
The Overview: April 2021
Flowers are blooming all around us, people are beginning to rediscover the things that matter most, and every day, OCRA grantees are making strides in understanding even more about ovarian … Continued
OCRA Co-Signs Letter to President Biden Supporting HARPA
On April 9, President Biden released his discretionary funding request for fiscal year 2022. Within the request, the President announced the creation of an agency that would take on high-risk, … Continued
Urgent: Tell Your U.S. Representative to Support a $10 Million Increase to OCRP
On Friday, March 19, U.S. House Representatives Grace Meng (D-NY), Brian Fitzpatrick (R-PA), and Norma Torres (D-CA) released a bipartisan “Dear Colleague” letter urging the House Appropriations Defense Subcommittee to … Continued
The Overview: March 2021
The snow is (finally!) melting in the areas where many of us at OCRA work and live, the COVID vaccine is rolling out, and there is so much work being … Continued
Ovarian Cancer Advocates Unite for Spring Advocacy Day
OCRA’s Spring Advocacy Day, held March 8-9, looked a little bit different this year. For starters, we met online rather than in Washington D.C. But while the natural and obvious … Continued
OCRA Awards Prizes in Ovarian Cancer Research
Each year, OCRA honors individuals doing important and notable work in the ovarian cancer field with a research prize to help propel their future discoveries. Individuals are selected by members … Continued
Advocacy in Action: A Year in Ovarian Cancer Policy Progress
As we gear up for our first ever virtual Spring Advocacy Day — which will welcome more than 200 participants, double our usual crowd! — we couldn’t help but take … Continued
A False Alarm, and a Wake-Up Call to Fight Ovarian Cancer
Imagine, if you will, a scene from yesteryear: rows of telephone operators sitting in front of giant switchboards, lights blinking on and off in seemingly random patterns, hands working quickly … Continued
Medicare Patients Pay High Cost for PARP Inhibitors
PARP inhibitors have proven to be particularly valuable in improving progression-free survival for patients with certain types of ovarian cancer. But unfortunately, these gains come at a high financial cost … Continued
Letter to President Biden & Leaders of State Public Health Departments: Prioritizing COVID-19 Vaccines for Patients With Cancer and Survivors of Cancer
February 16, 2021 President Joseph R. Biden, Jr.The White House1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr. President: On behalf of a broad spectrum of organizations, cancer centers, and other … Continued